Quickly and accurately diagnosing Alzheimer’s disease is critical to mitigating disease trajectory and optimizing treatment success. However, the current diagnostic landscape is fraught with lengthy wait times, high costs, and limited healthcare resources. Blood-based biomarkers hold tremendous promise for alleviating the current pain points related to how and when Alzheimer’s disease is diagnosed, including enabling earlier and more accurate diagnosis.
Download this ebook to learn about the evolving role of blood-based biomarkers in alleviating the current diagnostic burden of neurodegenerative disease.
